13F Filings History of ADAR1 Capital Management, LLC
- Latest 13F filing
- Q1 2026 - 18 May 2026
- Latest reported 13F value
- $1,649,553,719
- Largest 13F holdings
-
ABVX PTGX ROIV IMVT SPY TERN CYTK CRNX BOXX DNLI BEAM ZLAB
+8 more
SEPN VIR DBVT AVR INSP SRRK RYTM SYRE - Form 13F summary
-
- ADAR1 Capital Management, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- ADAR1 Capital Management, LLC reported 293 equity holdings with a total reported market value of $1,649,553,719 for Q1 2026. Top reported holdings included ABVX, PTGX, ROIV, IMVT, and SPY.
- Manager signature
- Stephen Scipione - Chief Compliance Officer
- Manager location
- Austin, TX
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow ADAR1 Capital Management, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2026
Latest value
$1,649,553,719
Quarter delta
+$312,603,009
Accepted
15 May 2026, 20:25
Rows shown
1-10 of 10
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 293 | $1,649,553,719 | +$525,918,473 | -$232,315,375 | +$293,603,098 | ABVX, PTGX, ROIV, IMVT, SPY | 13F-HR | 15 May 2026, 20:25 |
| Q4 2025 | 249 | $1,336,950,710 | +$346,210,387 | -$265,340,068 | +$80,870,319 | ABVX, PTGX, ROIV, IMVT, RNA | Restatement | 18 Feb 2026, 14:09 |
| Q3 2025 | 199 | $1,002,579,003 | +$268,372,697 | -$281,615,084 | -$13,242,387 | ABVX, KROS, PTGX, ROIV, BOXX | 13F-HR | 14 Nov 2025, 14:40 |
| Q2 2025 | 201 | $615,875,250 | +$194,647,169 | -$126,297,699 | +$68,349,470 | KROS, PTGX, BOXX, ZLAB, ABVX | 13F-HR | 14 Aug 2025, 13:12 |
| Q1 2025 | 196 | $519,713,260 | +$153,682,729 | -$98,513,133 | +$55,169,596 | PTGX, BOXX, ROIV, ZLAB, IMVT | 13F-HR | 15 May 2025, 13:50 |
| Q4 2024 | 199 | $485,210,915 | +$158,639,721 | -$218,277,675 | -$59,637,954 | ROIV, PTGX, BOXX, ZLAB, IMVT | 13F-HR | 13 Feb 2025, 10:06 |
| Q3 2024 | 258 | $596,545,930 | +$213,156,739 | -$172,374,144 | +$40,782,595 | CYTK, PTGX, BBIO, BOXX, ROIV | 13F-HR | 14 Nov 2024, 09:37 |
| Q2 2024 | 245 | $496,609,990 | +$244,393,592 | -$103,525,752 | +$140,867,840 | PTGX, CYTK, ROIV, BOXX, BBIO | 13F-HR | 13 Aug 2024, 11:11 |
| Q1 2024 | 239 | $366,271,492 | +$219,503,389 | -$121,718,112 | +$97,785,277 | BOXX, ROIV, ALNY, PTGX, CYTK | 13F-HR | 15 May 2024, 10:45 |
| Q4 2023 | 150 | $223,594,442 | $0 | $0 | $0 | RPRX, KROS, ROIV, ABUS, CYTK | 13F-HR | 14 Feb 2024, 16:45 |